The Latest Cardiac and Vascular News
Orlando, Fla., April 04, 2019 (GLOBE NEWSWIRE) — Patients with a newer version of a common heart pump experienced a reduced aggregate burden of bleeding and stroke rates – and no pump thrombosis requiring surgical exchange, compared to patients with the predecessor device. The MOMENTUM3 study was a randomized controlled […]
Orlando, Florida, April 03, 2019 (GLOBE NEWSWIRE) — The Journal of Heart and Lung Transplantation is releasing its themed issue on Mechanical Circulatory Support to coincide with the 39th Annual Meeting of the International Society for Heart and Lung Transplantation being held April 3 – 6 in Orlando, Florida. This special issue highlights […]
Orlando, Florida, April 03, 2019 (GLOBE NEWSWIRE) — A common heart pump has traditionally been seen as only a short-term option for heart-failure patients but new research shows it may provide a similar quality of support as a permanent treatment in patients ineligible for transplantation. The study, part of the […]
ASHBURN, Va., April 2, 2019 /PRNewswire/ — American College of Clinical Pharmacology® & Cardiac Safety Research Consortium are pleased to announce the publication of their first co-authored paper, “The Potential Role of the J-Tpeak Interval in Pro-arrhythmic Cardiac Safety − Current State-of-the-Science from the American College of Clinical Pharmacology and the Cardiac Safety Research Consortium,” in The […]
MINNEAPOLIS & AACHEN, Germany–(BUSINESS WIRE)–Hemovent GmbH announced today that its next-generation ECMO (ExtraCorporeal Membrane Oxygenation) system, MOBYBOX, has been validated in a pilot in vivo study by Minnesota Resuscitation Consortium, which is designing a ‘super ambulance’ that will be equipped with the latest technology to advance treatment of cardiac-arrest emergency patients. A ‘super […]
NEW YORK and MELBOURNE, Australia, March 26, 2019 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, today announced that the International Center for Health Outcomes and Innovation Research (InCHOIR) at the Icahn School of Medicine at Mount Sinai and Mesoblast have entered into […]
SEATTLE, March 26, 2019 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™”), the industry’s first P-wave centric™ ambulatory cardiac patch monitor and arrhythmia detection device, announced it has been selected as one of four winners of the Impact […]
CARLSBAD, Calif., March 25, 2019 /PRNewswire/ — Acutus Medical today announced the publication of “High Resolution Non-Contact Charge Density Mapping of Endocardial Activation” in JCI Insight. This foundational manuscript indicates that charge mapping enables unmatched visualization of the conduction patterns and localized non-pulmonary vein (PV) therapeutic targets in patients with atrial arrhythmias, such as atrial […]
MARLBOROUGH, Mass., March 25, 2019 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced the European CE Mark approval of the HeartLight X3 Endoscopic Ablation System. The HeartLight X3 System is a third generation technology building upon the advanced features of the HeartLight Endoscopic […]
ORANGEBURG, New York, March 21, 2019 /PRNewswire/ — Impulse Dynamics, developer of the implantable Optimizer® Smart System for delivering CCM™ therapy, announced today that it has received approval from the United States Food and Drug Administration for its first-in-class Optimizer Smart System (link to FDA announcement: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm634103.htm). Designed to address a significant unmet […]
